In ccRCC, TRIM2 functions as an antitumor gene as well as a specific prognostic indicator, and its exogenous overexpression suppresses cell proliferation, migration, and invasion (29). This evidence concerns the gene TRIM2 and nonpapillary renal cell carcinoma.